Is Takeda Pharmaceutical Company Limited overvalued?

Takeda Pharmaceutical Company Limited (TAK) looks undervalued — trading about 109% below its fair value.

Undervalued

Price

$17.86

Fair value

$37.25

Current P/E

10.4

Normal P/E

21.7

Market cap

$56.83B

Dividend yield

3.4%

Return on equity

2.4%

Sector

Healthcare

Fair value compares TAK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 2 Oct 2026.

Related stocks